Tracking-software maker stirs phone-privacy fears

Little known software installed on millions of smartphones is raising fresh questions about what data are being collected from mobile devices, where it's going and what it is being used for.

Read Article...

User

Ramky Infra bags two NHDP projects worth Rs2,240 cr

Ramky has received an order worth Rs1,207 crore for six-laning of the Agra-Etawah Bypass section of NH-2 under the NHDP Phase V in Uttar Pradesh

Ramky Infrastructure, the flagship company of the Ramky Group, said it bagged two major orders worth Rs2,240 crore under the National Highways Development Project (NHDP).

The company has received an order worth Rs1,207 crore for six-laning of the Agra-Etawah Bypass section of NH-2 under the NHDP Phase V in Uttar Pradesh, to be executed as a BOT toll basis on design build finance operate and transfer pattern, the company said in a statement.

The concession period for the project is 30 years, including the construction period of 910 days, it said. The second order worth Rs1,033.65 crore is for four laning of the Hospet-Chitradurga section of NH-13 in Karnataka under NHDP Phase III on DBFOT in BOT.

The concession period for this project is 25 years, including the construction period of 910 days, the release said.

In the late afternoon, Ramky Infrastructure was trading at around Rs217.60 per share on the Bombay Stock Exchange, 0.23% up from the previous close.

User

Lupin receives FDA approval for generic Solodyn tablets

Medicis’s Solodyn (Minocycline HCI, USP) Extended-release tablets had sales of $750 million as per IMS September 2011 data

Pharma major, Lupin Ltd, announced that its subsidiary, Lupin Pharmaceuticals Inc. has received final approval for its Minocycline hydrochloride extended-release tablets 45mg, 55mg, 90mg and 135mg strengths as well as tentative approval for its Minocycline HCl extended release tablets 65mg, 80mg, 105mg and 115mg strengths from the US Food and Drug Administration (FDA) for the company’s Abbreviated New Drug Application (ANDA) to market a generic version of Medicis Pharmaceutical Corporation’s (Medicis) Solodyn (Minocycline HCI, USP) extended-release tablets.

Solodyn is an oral antibiotic approved to treat only the red, pus-filled pimples of moderate to severe acne in patients 12 years of age and older. Medicis’s Solodyn (Minocycline HCI, USP) Extended-release tablets had sales of $750 million as per IMS September 2011 data.

In the late afternoon, Lupin was trading at around Rs469.35 per share on the Bombay Stock Exchange, 0.7% up from the previous close.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)